Marco Scarpa
Azienda Ospedale Universita Padova
Appearances
- DateMay 9, 2023BACKGROUND: Gastroesophageal reflux disease (GERD), with or without hiatal hernia (HH), affects millions of individuals worldwide, with a significant economic impact and loss of health-related quality of life…
Presenter
Speakers
Azienda Ospedale Universita PadovaAzienda Ospedale Universita Padova - DateMay 9, 2023Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Presenters
Azienda Ospedale Universita Padova - DateMay 8, 2023BACKGROUND: Local excision (LE) with transanal endoscopic microsurgery (TEM) is an established alternative to radical resection in select early rectal cancers and high-risk patients…
Presenter
Speakers
Azienda Ospedale Universita PadovaAzienda Ospedale Universita Padova - DateMay 6, 2023Socioeconomic status (SES) has proven significant impact on colorectal cancer (CRC) outcomes. Lower SES has correlated with increased comorbidities, risk of postoperative complications, and inadequate adherence to treatment guidelines…
Presenter
Speakers
Azienda Ospedale Universita PadovaAzienda Ospedale Universita Padova - DateMay 7, 2023SOCIETY: SSAT
Moderators
Azienda Ospedale Universita PadovaMedStar Washington Hospital CenterOregon Health & Science Univ - DateMay 7, 2023INTRODUCTION: Due to its rarity, anal adenocarcinoma (AA) does not have a standardized staging system. The tumor (T) stage of an adenocarcinoma arising from the anal canal could be based on depth of invasion, as for rectal adenocarcinoma, or on size, as in anal squamous cell carcinoma…
Speakers
Azienda Ospedale Universita PadovaAzienda Ospedale Universita PadovaPresenter
- DateMay 6, 2023LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Presenter
Speakers
Azienda Ospedale Universita PadovaAzienda Ospedale Universita Padova - DateMay 18, 2024BACKGROUND: Around 20-25% of ulcerative colitis patients undergo restorative proctocolectomy with ileal pouch-anal anastomosis. Pouchitis is an idiopathic inflammatory disease that may occur in ileal pouches, and it can lead to ileal pouch failure…
Presenter
Speakers
Azienda Ospedale Universita Padova - DateMay 18, 2024BACKGROUND Stage II colorectal cancer should undergo adjuvant therapy only in the presence of risk factors and vascular, lymphatic, and perineural invasion (VELIPI) are risk factors for recurrence after surgery…
Presenter
Speakers
Azienda Ospedale Universita Padova - DateMay 19, 2024BACKGROUND: Adjuvant therapy after rectal cancer surgery is indicated in T4N0 or any T and nodal metastasis and/or risk factors for recurrences…
Speakers
Azienda Ospedale Universita PadovaPresenter
- DateMay 21, 2024BACKGROUND: Inflammatory bowel disease encompasses two types of idiopathic intestinal disease, ulcerative colitis (UC) and Crohn's disease (CD) that are differentiated by their location and depth of involvement in the bowel wall…
Speakers
Presenter
- DateMay 18, 2024ELEVATED RED CELL DISTRIBUTION WIDTH TO PLATELET RATIO IS ASSOCIATED WITH LOW GRADE DYSPLASIA IN IBD
Moderators
Universita Vita Salute San RaffaeleUniversity of WashingtonOregon Health & Science UnivSpeakers
Azienda Ospedale Universita PadovaThe Ohio State Wexner Medical Center